The SBIR/STTR Program is offering this Commercialization Readiness Pilot (CRP) grant to facilitate the transition of previously or currently funded SBIR/STTR Phase II and IIB projects toward commercialization. This grant is specifically designed to provide essential additional support for technical assistance and crucial later-stage research and development, which often falls outside typical Phase II funding. Support may encompass activities like independent replication of key studies, Investigational New Drug (IND)-enabling studies, manufacturing costs, or regulatory assistance. This program aims to bridge the gap to market readiness for small business concerns (SBCs) by addressing critical development needs. Please note, direct clinical trials are not permitted under this funding opportunity.
Opportunity ID: 328049
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-129 |
| Funding Opportunity Title: | SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 10, 2020 |
| Last Updated Date: | Mar 14, 2022 |
| Original Closing Date for Applications: | Apr 05, 2022 |
| Current Closing Date for Applications: | Apr 05, 2023 |
| Archive Date: | May 05, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award. Clinical Trials are not accepted under this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-129.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date as per NOT-OD-22-086 | Mar 14, 2022 | |
| Jul 10, 2020 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-129 |
| Funding Opportunity Title: | SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 10, 2020 |
| Last Updated Date: | Mar 14, 2022 |
| Original Closing Date for Applications: | Apr 05, 2022 |
| Current Closing Date for Applications: | Apr 05, 2023 |
| Archive Date: | May 05, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award. Clinical Trials are not accepted under this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-129.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-129 |
| Funding Opportunity Title: | SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 10, 2020 |
| Last Updated Date: | Jul 10, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 05, 2022 |
| Archive Date: | May 11, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award. Clinical Trials are not accepted under this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-129.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
Folder 328049 Full Announcement-PAR-20-129 -> PAR-20-129-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00262506 | Mar 05, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270923 | Dec 16, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278501 | Nov 16, 2022 | Apr 05, 2023 | View |
Package 1
Mandatory forms
328049 RR_SF424_2_0-2.0.pdf
328049 PHS398_CoverPageSupplement_5_0-5.0.pdf
328049 RR_OtherProjectInfo_1_4-1.4.pdf
328049 PerformanceSite_2_0-2.0.pdf
328049 RR_KeyPersonExpanded_2_0-2.0.pdf
328049 RR_Budget_1_4-1.4.pdf
328049 PHS398_ResearchPlan_4_0-4.0.pdf
328049 SBIR_STTR_Information_1_3-1.3.pdf
328049 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328049 RR_SubawardBudget30_1_4-1.4.pdf
328049 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
328049 RR_SF424_5_0-5.0.pdf
328049 PHS398_CoverPageSupplement_5_0-5.0.pdf
328049 RR_OtherProjectInfo_1_4-1.4.pdf
328049 PerformanceSite_4_0-4.0.pdf
328049 RR_KeyPersonExpanded_4_0-4.0.pdf
328049 RR_Budget_3_0-3.0.pdf
328049 PHS398_ResearchPlan_4_0-4.0.pdf
328049 SBIR_STTR_Information_3_0-3.0.pdf
328049 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328049 RR_SubawardBudget30_3_0-3.0.pdf
328049 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
328049 RR_SF424_5_0-5.0.pdf
328049 PHS398_CoverPageSupplement_5_0-5.0.pdf
328049 RR_OtherProjectInfo_1_4-1.4.pdf
328049 PerformanceSite_4_0-4.0.pdf
328049 RR_KeyPersonExpanded_4_0-4.0.pdf
328049 RR_Budget_3_0-3.0.pdf
328049 PHS398_ResearchPlan_5_0-5.0.pdf
328049 SBIR_STTR_Information_3_0-3.0.pdf
328049 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
328049 RR_SubawardBudget30_3_0-3.0.pdf
328049 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
